The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Effective disaster response and management is a collaborative work
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Convergent action on AMR identified as an important area of intervention
Subscribe To Our Newsletter & Stay Updated